May 17, 2022 Price forecast | 2 weeks: 3.92% | 1 month: 2.74% | 3 months: 24.75% | Premium Forecast


ADVM stock forecast

Our latest prediction for Adverum Biotechnologies Inc's stock price was made on the May 17, 2022 when the stock price was at 0.83$.

In the short term (2weeks), ADVM's stock price should outperform the market by 3.92%. During that period the price should oscillate between -11.57% and +22.37%.

In the medium term (3months), ADVM's stock price should outperform the market by 24.75%. During that period the price should oscillate between -39.19% and +67.60%.

Create a solid portfolio with ADVM

Add ADVM to your portfolio and optimize it!


About Adverum Biotechnologies Inc

Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema.

At the moment the company generates 99M USD in revenues.

On its last earning announcement, the company reported a loss of -1.66$ per share.

The book value per share is 3.72$

Adverum Biotechnologies Inc website


Three months stock forecastMay 17, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
99M - -155M -155.37% -160M -1.66 - - 100M 3.72 - - -